Structure Therapeutics Correlations
GPCR Stock | 17.94 0.19 1.05% |
The current 90-days correlation between Structure Therapeutics and Terns Pharmaceuticals is 0.44 (i.e., Very weak diversification). The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Structure Therapeutics Correlation With Market
Good diversification
The correlation between Structure Therapeutics America and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and DJI in the same portfolio, assuming nothing else is changed.
Structure | Build AI portfolio with Structure Stock |
Moving against Structure Stock
0.73 | WF | Woori Financial Group Earnings Call Tomorrow | PairCorr |
0.71 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
0.7 | FNMFO | Federal National Mortgage Earnings Call This Week | PairCorr |
0.66 | BAC-PL | Bank of America | PairCorr |
0.62 | KB | KB Financial Group | PairCorr |
0.6 | CGEN | Compugen | PairCorr |
0.59 | KMDA | Kamada | PairCorr |
0.58 | NKTR | Nektar Therapeutics | PairCorr |
0.54 | PFE | Pfizer Inc | PairCorr |
0.44 | JNJ | Johnson Johnson | PairCorr |
0.43 | AVAL | Grupo Aval | PairCorr |
0.7 | CVX | Chevron Corp | PairCorr |
0.62 | IBM | International Business Earnings Call Tomorrow | PairCorr |
0.61 | CSCO | Cisco Systems | PairCorr |
0.57 | AA | Alcoa Corp | PairCorr |
0.52 | DIS | Walt Disney | PairCorr |
0.51 | WFC-PL | Wells Fargo | PairCorr |
0.51 | MSFT | Microsoft Aggressive Push | PairCorr |
0.51 | AXP | American Express | PairCorr |
0.46 | INTC | Intel Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Structure Stock performing well and Structure Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Structure Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TERN | 3.72 | 1.34 | 0.30 | 3.06 | 2.99 | 9.43 | 21.70 | |||
DAWN | 2.36 | (0.31) | 0.00 | (0.10) | 0.00 | 5.90 | 16.05 | |||
ABOS | 4.00 | 0.61 | 0.11 | 0.95 | 4.21 | 7.69 | 29.86 | |||
AMLX | 3.86 | 1.11 | 0.27 | 1.06 | 3.50 | 9.51 | 31.80 | |||
MLTX | 2.54 | 0.54 | 0.18 | 1.09 | 2.22 | 5.51 | 22.30 | |||
MLYS | 2.42 | (0.12) | (0.04) | 0.01 | 3.22 | 4.38 | 12.76 | |||
ACRV | 4.34 | 0.26 | (0.01) | (0.05) | 5.50 | 6.28 | 60.92 | |||
PRME | 6.95 | 1.99 | 0.32 | 1.15 | 5.73 | 21.58 | 41.91 | |||
THRD | 0.31 | 0.08 | (0.16) | 7.94 | 0.00 | 0.58 | 3.40 |
Structure Therapeutics Corporate Management
Lani Ibarra | Senior Operations | Profile | |
Hui Lei | Senior Chemistry | Profile | |
Xichen Lin | Chief Officer | Profile | |
Yingli Ma | Chief Officer | Profile | |
Fang Zhang | Executive Biology | Profile |